Funding
CURRENT
PKD Foundation
“Prioritizing drug repurposing candidates for PKD with machine learning and multimodal networks”
2024-2026
R01 NIH NINDS
MPIs: Furnari & Miller
co-I: Lasseigne
“Therapeutic targeting mesenchymal transition in newly diagnosed and recurrent GBM” 2024-2028
NIH U54 (NIDCR)
Yoder & Might (Multi-PIs), Lasseigne (Co-I and Co-Director, Bioinformatics Section) 2020-2025
R01 NIH NCI
MPIs: Miller, Furnari, O’Rourke; co-I: Lasseigne
“Credentialing next-generation human glioma models for precision therapeutics”
2022-2026
SETBP1 Society
“Identifying and Prioritizing Drug Repurposing Candidates for SETBP1-HD via Genomics-Driven Approaches” 2024-2025
UAB Pilot Center for Precision Animal Modeling (C-PAM)
U54 NIH NIDCR
PIs: Yoder and Might; co-I and Bioinformatics Core co-Director: Lasseigne“UAB Pilot Center for Precision Animal Modeling (C-PAM)”
2020-2025
Department of Cell, Developmental and Integrative Biology 2nd R01 Pilot Award
“Prioritizing ADPKD therapeutic strategies by mapping cross-tissue and cross-species cell regulatory states and disease signatures”
2024-2025
R01 NIH NIDDK
PI: Yoder; co-I Lasseigne
“Injury Response Mediated Pathogenesis in Renal Ciliopathies"
2023-2026
R01 NIH NIA
J
PI: Cortes; co-I Lasseigne
“Exercise-Associated Signaling Against CNS Aging and Alzheimer's Disease”
2022-2027
R25 NIH NHGRI
“Summer Undergraduate Research Experiences in Genomic Medicine (SURE-GM)”
2018-2029
COMPLETED RESEARCH SUPPORT
CDIB Collaborative Pilot
co-PIs: Lasseigne & Cortes/Sun
“Transcript diversity in the developing c. elegans nervous system"
2022-2023
AD Supplement NIH NHGRI
“Alzheimer’s-focused supplement for Integrating multidimensional genomic data to discover clinically-relevant predictive models”
2021-2022
R00 NIH Pathway to Independence Award, NHGRI
“Integrating multidimensional genomic data to discover clinically-relevant predictive models.”
2019-2022
UAB AMC21 Multi-PI
PI: Mrug; co-I: Lasseigne
“PKD1 and PKD2 Functional Variants Characterization Center”
2021-2023
R03 NIH NIDCR
“Common Fund data to inform rare disease preclinical models and prioritize drug repurposing"
2020-2021
R01 NIH NINDS
PI: Napierala; co-I: Lasseigne
“GAA repeats induced epigenetic silencing in Friedreich’s Ataxia.”
2012-2022
CCTS Pilot Program
PIs: Stern and Lasseigne
“Integrative analysis of telomerase and aging across human cancers.”
2020-2021
ACS-IRG Junior Faculty Development Award
“Defining circulating tumor profiles in human glioblastoma patient-derived mouse xenograft models for drug repurposing prioritization.”
2020-2021
OT2 NIH NCATS
“Doc Sherlock: An Autonomous Relay Agent for Discovering the "Unknown Knowns" in Precision Medicine”
2020-2021
K99 NIH Pathway to Independence Award, National Human Genome Research Institute
“Integrating multidimensional genomic data to discover clinically-relevant predictive models.”
2018-2019
NVIDIA GPU Grant Award, Nvidia
“Integrating multidimensional data with deep neural networks to discover clinically-relevant predictive models.”
2018
Cancer Genomics Cloud Collaborative Project Award, Seven Bridges
“Dosage effects, context-dependency, and tissue specificity of tumor suppressor genes.”
2017
William J. Maier III Fellowship in Cancer Prevention, Prevent Cancer Foundation
“Development of an early diagnostic urine test for kidney cancer.”
2016-2018
Core Lab Grant Program
PI: Lasseigne, co-I: George
“Identification of macrophage subpopulations by differentially expressed surface markers and gene expression profiles to determine macrophage subpopulations changes in the kidney following acute kidney injury”
2023-2024